Clinical Trials Browser

INDUSTRY × Everolimus × Thoracic × Clear all

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Colorectal Neoplasms, Triple Negative Breast Neoplasms

NCT02071862 2022-07-20

Study of the Glutaminase Inhibitor CB-839 in Solid Tumors

Phase 1 Completed

210 enrolled

BreastGenitourinaryOther solid neoplasmThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Mesothelioma, Triple Negative Breast Neoplasms

NCT00434174 2020-12-21

Safety of Everolimus and Pemetrexed in Lung Cancer Patients

Phase 1 Completed

48 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00456833 2020-12-21

Combination of RAD001 and Erlotinib in Patients With Advanced Non Small Cell Lung Cancer Previously Treated Only With Chemotherapy

Phase 1 Completed

248 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00466466 2020-12-21

Safety of RAD001 in Combination With Cisplatin and Etoposide in Lung Cancer Patients

Phase 1 Completed

20 enrolled

Thoracic

Small Cell Lung Carcinoma

NCT01115803 2019-02-05

A Study of LY2584702 With Erlotinib or Everolimus in Participants With Solid Tumors

Phase 1 Terminated

29 enrolled 19 charts

EndocrineGenitourinaryNETThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Neoplasm Metastasis, Neuroendocrine Tumors

NCT00124280 2016-11-18

Study Investigating the Effect of Everolimus Monotherapy in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)

Phase 2 Completed

85 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT01427946 2014-11-13

Phase 1b/2 Study of Retaspimycin HCl (IPI-504) in Combination With Everolimus in KRAS Mutant Non-small Cell Lung Cancer

Phase 1/2 Completed

47 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00457119 2013-02-12

Combination of RAD001 With Carboplatin, Paclitaxel and Bevacizumab in Non-small-cell Lung Cancer (NSCLC) Patients

Phase 1 Completed

69 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

Clinical Trials

A Study of PDR001 in Combination With LCL161, Everolimus or Panobinostat

Study of the Glutaminase Inhibitor CB-839 in Solid Tumors

Safety of Everolimus and Pemetrexed in Lung Cancer Patients

Combination of RAD001 and Erlotinib in Patients With Advanced Non Small Cell Lung Cancer Previously Treated Only With Chemotherapy

Safety of RAD001 in Combination With Cisplatin and Etoposide in Lung Cancer Patients

A Study of LY2584702 With Erlotinib or Everolimus in Participants With Solid Tumors

Study Investigating the Effect of Everolimus Monotherapy in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)

Phase 1b/2 Study of Retaspimycin HCl (IPI-504) in Combination With Everolimus in KRAS Mutant Non-small Cell Lung Cancer

Combination of RAD001 With Carboplatin, Paclitaxel and Bevacizumab in Non-small-cell Lung Cancer (NSCLC) Patients